MedVi Expands Access to GLP-1 Medication – Compounded Semaglutide for Healthy Living
NEWARK, DE - MedVi Wellness, a leading telehealth provider in medical weight management, has announced the launch of its nationwide GLP-1 medication program, providing compounded semaglutide in both injectable and oral forms. Starting at $179 per month with no insurance required, MedVi offers an affordable, physician-guided alternative to high-cost brand-name drugs such as Wegovy® and Ozempic®.
The GLP-1 medication program combines compounded semaglutide with continuous clinical oversight, 24/7 support, and fast delivery, giving patients an accessible path to sustainable weight loss backed by medical expertise.
GLP-1 Medications Driving a New Era in Weight Management
Semaglutide, a GLP-1 receptor agonist, works by reducing appetite, improving satiety, and stabilizing blood sugar levels. Clinical studies show that GLP-1 medications can help patients achieve 15–18% average weight reduction over time when combined with healthy lifestyle changes.
“GLP-1 medications like semaglutide have redefined medical weight loss,” said a MedVi Wellness spokesperson. “By offering compounded semaglutide at an affordable price point with physician oversight, we are eliminating the barriers that keep most patients from accessing this transformative therapy.”
Key Features of MedVi’s GLP-1 Medication Program
Compounded Semaglutide Injections – Once-weekly dosing with pre-filled pens
Oral Semaglutide Tablets – A non-injectable option for daily use
Physician-Supervised Treatment – Personalized dosing plans from board-certified providers
Continuous Monitoring and Support – Unlimited check-ins and 24/7 medical access
Fast, Nationwide Delivery – Temperature-controlled shipping direct to patients
MedVi’s program also includes GLP-1 medication for blood sugar control, benefiting patients managing type 2 diabetes while addressing weight and metabolic health together.
Addressing Drug Shortages and Rising Demand
Due to ongoing shortages of brand-name GLP-1 drugs like Wegovy® and Ozempic®, compounded semaglutide has become a vital alternative. MedVi sources exclusively from FDA-regulated, PCAB-accredited compounding pharmacies, ensuring pharmaceutical-grade standards and verified potency.
“By combining GLP-1 medication expertise with streamlined telehealth delivery, MedVi is meeting demand where traditional healthcare has fallen short,” the spokesperson added. “Patients no longer need to wait months or pay thousands for care.”
Why MedVi?
GLP-1 medications starting at $179/month
FDA-regulated compounding facilities and U.S.-licensed physicians
Transparent, no-membership pricing
Money-back guarantee with ongoing medical guidance
Service availability in all 50 U.S. states
How It Works
Online Medical Evaluation: Complete a secure health assessment at medvi.io.
Physician Review: A board-certified provider approves treatment if medically appropriate.
Medication Delivery: GLP-1 medication ships directly to the patient’s home, with instructions included.
Ongoing Support: MedVi provides unlimited consultations, dose adjustments, and 24/7 access to licensed clinicians.
About MedVi Wellness
MedVi Wellness is a U.S.-based telehealth platform dedicated to weight loss and metabolic care through GLP-1 medications. By pairing clinical expertise with convenience and affordability, MedVi empowers patients to achieve lasting health results with doctor-led guidance and transparent pricing.
Media Contact
Company Name: MedVi Wellness
Contact Person: Media Relations
Email: Send Email
Phone: (323) 690-1564
Address:131 Continental Dr. Ste 305
City: Newark
State: DE 19713
Country: United States
Website: medvi.io
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: MedVi Expands Access to GLP-1 Medication - Compounded Semaglutide for Healthy Living
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]
